These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 31659070
1. Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested Platform. Muluhngwi P, Sharp CN, Pozzi N, Elin RJ, Jortani SA. J Appl Lab Med; 2019 Nov; 4(3):323-330. PubMed ID: 31659070 [Abstract] [Full Text] [Related]
2. Method comparison of three serum free light chain assays on the Roche Cobas 6000 c501 chemistry analyzer. Augustijn D, Jacobs JFM, Russcher H. Clin Chem Lab Med; 2022 Feb 23; 60(3):379-385. PubMed ID: 34969184 [Abstract] [Full Text] [Related]
3. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, Kyle RA. Clin Chem; 2002 Sep 23; 48(9):1437-44. PubMed ID: 12194920 [Abstract] [Full Text] [Related]
4. Comparison of 2 Serum Free Light Chain Assays with Creatinine Normal and Abnormal Populations Demonstrates the Need for Standardization. Griffiths M, Cheng PL, Wang XY, Schneider R, Kulasingam V. J Appl Lab Med; 2024 Sep 03; 9(5):978-988. PubMed ID: 38973026 [Abstract] [Full Text] [Related]
5. Serum free light chain analysis: persisting limitations with new kids on the block. Van Hoovels L, Vercammen M, Nevejan L, Cornette M, Briers PJ, Deeren D, Van Droogenbroeck J, Fostier K, De Smet D. Clin Chem Lab Med; 2022 Aug 26; 60(9):1440-1448. PubMed ID: 35781357 [Abstract] [Full Text] [Related]
6. Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study. Cotten SW, Shajani-Yi Z, Cervinski MA, Voorhees T, Tuchman SA, Korpi-Steiner N. Clin Biochem; 2018 Aug 26; 58():100-107. PubMed ID: 29885308 [Abstract] [Full Text] [Related]
7. Analytical validation of new ELISAs for the quantitation of polyclonal free light chains and comparison to existing assays for healthy and patient samples. Heaney JLJ, Campbell JP, Goodall M, Plant T, Shemar M, Hand C, Drayson MT. J Immunol Methods; 2020 Mar 26; 478():112713. PubMed ID: 31783021 [Abstract] [Full Text] [Related]
8. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool. Campbell JP, Heaney JL, Shemar M, Baldwin D, Griffin AE, Oldridge E, Goodall M, Afzal Z, Plant T, Cobbold M, Jefferis R, Jacobs JF, Hand C, Drayson MT. Clin Chem Lab Med; 2017 Mar 01; 55(3):424-434. PubMed ID: 27505089 [Abstract] [Full Text] [Related]
9. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis. Hoedemakers RM, Pruijt JF, Hol S, Teunissen E, Martens H, Stam P, Melsert R, Te Velthuis H. Clin Chem Lab Med; 2011 Nov 23; 50(3):489-95. PubMed ID: 22098433 [Abstract] [Full Text] [Related]
10. Limitations of Free Light Chain Assays caused by the Matrix Effect. Farnsworth CW, Logsdon NM, Hayes JE, Rais R, Willrich MA, Gronowski AM. J Appl Lab Med; 2020 Mar 01; 5(2):311-319. PubMed ID: 32445382 [Abstract] [Full Text] [Related]
11. Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio. Rindlisbacher B, Schild C, Egger F, Bacher VU, Pabst T, Leichtle A, Andres M, Sédille-Mostafaie N. J Appl Lab Med; 2020 Jan 01; 5(1):114-125. PubMed ID: 32445339 [Abstract] [Full Text] [Related]
13. Evaluation of the N Latex FLC free light chain assay on the Siemens BN analyser: precision, agreement, linearity and variation between reagent lots. Pretorius CJ, Klingberg S, Tate J, Wilgen U, Ungerer JP. Ann Clin Biochem; 2012 Sep 01; 49(Pt 5):450-5. PubMed ID: 22764186 [Abstract] [Full Text] [Related]
14. Evaluation of the N-latex serum free light chain assay on the Siemens BNII analyzer and agreement with The Binding Site FreeLite assay on the SPAPlus. White-Al Habeeb NMA, Earle T, Spencer M, Blasutig IM. Clin Biochem; 2018 Jan 01; 51():90-96. PubMed ID: 28512013 [Abstract] [Full Text] [Related]
15. Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory. Caponi L, Romiti N, Koni E, Fiore AD, Paolicchi A, Franzini M. Crit Rev Clin Lab Sci; 2020 Mar 01; 57(2):73-85. PubMed ID: 31612753 [Abstract] [Full Text] [Related]
16. Diagnostic accuracy of salivary and serum-free light chain assays in primary Sjögren's syndrome: a pilot study. Sandhya P, Christudoss P, Kabeerdoss J, Mandal SK, Aithala R, Mahasampath G, Job V, Danda D. Int J Rheum Dis; 2017 Jun 01; 20(6):760-766. PubMed ID: 28036132 [Abstract] [Full Text] [Related]
17. Effects of Long-Term Storage on Serum Free Light Chain Stability. Hörber S, Klein R, Peter A. Clin Lab; 2019 May 01; 65(5):. PubMed ID: 31115238 [Abstract] [Full Text] [Related]
18. N Latex FLC - new monoclonal high-performance assays for the determination of free light chain kappa and lambda. Velthuis HT, Knop I, Stam P, van den Broek M, Bos HK, Hol S, Teunissen E, Fischedick KS, Althaus H, Schmidt B, Wagner C, Melsert R. Clin Chem Lab Med; 2011 Aug 01; 49(8):1323-1332. PubMed ID: 21663464 [Abstract] [Full Text] [Related]
19. Serum free light chain reference intervals in an Optilite and their influence on clinical guidelines. Morales-García LJ, Pacheco-Delgado MS. Clin Biochem; 2021 Jun 01; 92():54-60. PubMed ID: 33662349 [Abstract] [Full Text] [Related]